Summit identifies two new classes of antibiotics

Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT) identified two new types of narrow-spectrum antibiotics targeting new Neisseria gonorrhoeae targets that could help treat gonorrhea.

Summit presented its findings at the

Read the full 278 word article

User Sign In